Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - CVS HEALTH Corp | a06302020ex322.htm |
| EX-32.1 - EXHIBIT 32.1 - CVS HEALTH Corp | a06302020ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - CVS HEALTH Corp | a06302020ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - CVS HEALTH Corp | a06302020ex311.htm |
| EX-10.1 - EXHIBIT 10.1 - CVS HEALTH Corp | a06302020ex101.htm |
| 10-Q - 10-Q - CVS HEALTH Corp | a0630202010-q.htm |
Exhibit 15.1
Letter re: Unaudited Interim Financial Information
August 5, 2020
To the Shareholders and the Board of Directors of CVS Health Corporation
We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-238506 and Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated August 5, 2020, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that is included in its Form 10-Q for the quarter ended June 30, 2020.
/s/ Ernst & Young LLP
Boston, Massachusetts